School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Brian Pollack MD/PhD

  • Department of Dermatology
    Faculty
  • bppolla@emory.edu
Head shot of Brian Pollack

Academic Appointment

  • Assistant Professor, Department of Dermatology, Emory University School of Medicine

Education

Degrees

  • BA from Rutgers University
  • PhD from Graduate School of Biomedical Sciences-University of Medicine and Dentistry of New Jersey
  • MD from Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey

Research

Focus

  • Our laboratory is interested in understanding how oncogenic signal transduction impacts the expression of immune system genes. Specifically, we are interested in how activation of the epidermal growth factor receptor impacts the expression of MHC class I and class II molecules. Further, we are also interested in defining in vivo how inhibitors of oncogenic kinases influence T cell mediated immune responses.

Publications

  • Correction: Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes.
    BMC Genomics Volume: 26 Page(s): 291
    03/24/2025 Authors: Gibbs DC; McCrary MR; Moreno CS; Seldin L; Li C; Kamili NAH; Pollack BP
  • Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes.
    BMC Genomics Volume: 26 Page(s): 122
    02/10/2025 Authors: Gibbs DC; McCrary MR; Moreno CS; Seldin L; Li C; Kamili NAH; Pollack BP
  • Corrigendum to "Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma" [Journal of Controlled Release 357 (2023) 655-668].
    J Control Release Volume: 366 Page(s): 834 - 837
    02/01/2024 Authors: Kim J; Archer PA; Manspeaker MP; Avecilla ARC; Pollack BP; Thomas SN
  • Obesity-induced dysregulation of skin-resident PPAR+ Treg cells promotes IL-17A-mediated psoriatic inflammation.
    Immunity Volume: 56 Page(s): 1844 - 1861.e6
    08/08/2023 Authors: Sivasami P; Elkins C; Diaz-Saldana PP; Goss K; Peng A; Hamersky M; Bae J; Xu M; Pollack BP; Horwitz EM
  • Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma.
    J Control Release Volume: 357 Page(s): 655 - 668
    05/01/2023 Authors: Kim J; Archer PA; Manspeaker MP; Avecilla ARC; Pollack BP; Thomas SN
  • Characteristics of the dermatologic cases on a popular crowdsourcing platform.
    J Am Acad Dermatol Volume: 88 Page(s): 164 - 165
    01/01/2023 Authors: McCrary MR; Wu A; Pollack BP
  • Transcriptional profiling of cutaneous immunotoxicity from melanoma immunotherapy
    Volume: 142 Page(s): S5 - S5
    08/01/2022 Authors: Chang DY; Claussen H; Pollack B; Yeung H; Chen SC; Feldman R; Cole E
  • Cutaneous findings in myotonic dystrophy.
    JAAD Int Volume: 7 Page(s): 7 - 12
    06/01/2022 Authors: Kong HE; Pollack BP
  • Cannabinoids in dermatologic surgery.
    J Am Acad Dermatol Volume: 85 Page(s): 1565 - 1570
    12/01/2021 Authors: Kong HE; Pollack BP; Blalock TW
  • Epidermal growth factor modifies immune gene expression in keratinocytes and Melanoma
    Volume: 141 Page(s): B8 - B8
    09/01/2021 Authors: Gibbs DC; McCrary MR; Moreno CS; Pollack BP
  • Critical role of interferons in gastrointestinal injury repair.
    Nat Commun Volume: 12 Page(s): 2624
    05/11/2021 Authors: McElrath C; Espinosa V; Lin J-D; Peng J; Sridhar R; Dutta O; Tseng H-C; Smirnov SV; Risman H; Sandoval MJ
  • Interactive Classification of Whole-Slide Imaging Data for Cancer Researchers.
    Cancer Res Volume: 81 Page(s): 1171 - 1177
    02/15/2021 Authors: Lee S; Amgad M; Mobadersany P; McCormick M; Pollack BP; Elfandy H; Hussein H; Gutman DA; Cooper LAD
  • EPIDERMAL GROWTH FACTOR MODULATION OF CXCL10 IN KERATINOCYTES AND CUTANEOUS CANCERS
    Volume: 8 Page(s): A362 - A363
    11/01/2020 Authors: McCrary M; Gibbs D; Moreno C; Pollack B
  • Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy.
    Sci Transl Med Volume: 12
    09/30/2020 Authors: Francis DM; Manspeaker MP; Schudel A; Sestito LF; O'Melia MJ; Kissick HT; Pollack BP; Waller EK; Thomas SN
  • MAPK inhibition synergizes with TNF-alpha to promote the expression of STAT1, IRF-1 and MHC class I
    Volume: 140 Page(s): S94 - S94
    07/01/2020 Authors: Pollack BP; Chang Y
  • Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
    Mol Cancer Res Volume: 17 Page(s): 2395 - 2409
    12/01/2019 Authors: Chandrasekaran S; Sasaki M; Scharer CD; Kissick HT; Patterson DG; Magliocca KR; Seykora JT; Sapkota B; Gutman DA; Cooper LA
  • Antagonism of signaling through the vasoactive intestinal peptide receptor as a novel immunotherapy in preclinical models of melanoma
    Volume: 7
    11/06/2019 Authors: Ravindranathan S; Wang S; Pankove R; Francis D; Thomas S; Dhamsania R; Pollack B; Waller E
  • Palladium-based nanoparticles for the treatment of advanced melanoma
    Volume: 81 Page(s): AB98 - AB98
    10/01/2019 Authors: Bubley J; Elsey J; Zhu L; Rao S; Sasaki M; Pollack B; Yang L; Arbiser JL
  • Linking growth factors and immune actors: PTEN/PI3K signaling in cancer and the response to cytokines
    Volume: 79
    07/01/2019 Authors: Chandrasekaran S; Sasaki M; Pollack BP
  • PI3K signaling modulates the induction of MHC class I and II molecules by IFN-gamma
    Volume: 139 Page(s): S25 - S25
    05/01/2019 Authors: Pollack BP; Chandrasekaran S; Sasaki M
  • PTEN/PI3K signaling in cancer and the response to cytokines: From growth factors to immune actors.
    Volume: 37
    03/10/2019 Authors: Chandrasekaran S; Sasaki M; Pollack BP
  • Palladium based nanoparticles for the treatment of advanced melanoma.
    Sci Rep Volume: 9 Page(s): 3255
    03/01/2019 Authors: Elsey J; Bubley JA; Zhu L; Rao S; Sasaki M; Pollack BP; Yang L; Arbiser JL
  • Propranolol exhibits activity against hemangiomas independent of beta blockade.
    NPJ Precis Oncol Volume: 3 Page(s): 27
    01/01/2019 Authors: Sasaki M; North PE; Elsey J; Bubley J; Rao S; Jung Y; Wu S; Zou M-H; Pollack BP; Kumar J
  • Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.
    J Vasc Surg Volume: 68 Page(s): 137S - 151S.e2
    12/01/2018 Authors: Chadid T; Morris A; Surowiec A; Robinson S; Sasaki M; Galipeau J; Pollack BP; Brewster LP
  • Defining the impact of growth factors on antigen presentation
    Volume: 79 Page(s): AB99 - AB99
    09/01/2018 Authors: Balakrishnan V; Sasaki M; Pollack B
  • Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply.
    JAMA Dermatol Volume: 154 Page(s): 851 - 852
    07/01/2018 Authors: Weinstock MA; Lew RA; Shaw FM; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group
  • Linking MAPK inhibition and the response to TNF in melanoma.
    Volume: 36
    05/20/2018 Authors: Chandrasekaran S; Sasaki M; Pollack BP
  • Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma (cSCC)
    Volume: 36
    05/20/2018 Authors: Kudchadkar RR; Yushak ML; Lawson DH; Delman KA; Lowe MC; Goings M; McBrien S; Mckellar M; Sieja K; Maynard N
  • Interrogating PI3K to induce PD-L1 expression in oral carcinoma.
    Volume: 36
    05/20/2018 Authors: Chandrasekaran S; Sasaki M; Pollack BP
  • PI3-kinase signaling modulates the induction of MHC molecules by IFN-gamma
    Volume: 138 Page(s): S30 - S30
    05/01/2018 Authors: Chandrasekaran S; Sasaki M; Sapkota B; Pollack B
  • Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.
    J Clin Pharmacol Volume: 58 Page(s): 7 - 24
    01/01/2018 Authors: Kersh AE; Ng S; Chang YM; Sasaki M; Thomas SN; Kissick HT; Lesinski GB; Kudchadkar RR; Waller EK; Pollack BP
  • Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial.
    Clin Exp Dermatol Volume: 42 Page(s): 488 - 495
    07/01/2017 Authors: Pomerantz H; Chren M-M; Lew R; Weinstock MA; VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*
  • HMG-CoA synthase 1 is a synthetic lethal partner of BRAFV600E in human cancers.
    J Biol Chem Volume: 292 Page(s): 10142 - 10152
    06/16/2017 Authors: Zhao L; Fan J; Xia S; Pan Y; Liu S; Qian G; Qian Z; Kang H-B; Arbiser JL; Pollack BP
  • MAPK inhibition modulates the induction of MHC molecules by IFN-alpha 2b and TNF-alpha in human melanoma cells
    Volume: 137 Page(s): S143 - S143
    05/01/2017 Authors: Sasaki M; Sapkota B; Pollack B
  • Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.
    Melanoma Manag Volume: 4 Page(s): 13 - 37
    03/01/2017 Authors: Johnson MM; Leachman SA; Aspinwall LG; Cranmer LD; Curiel-Lewandrowski C; Sondak VK; Stemwedel CE; Swetter SM; Vetto J; Bowles T
  • Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.
    Cell Metab Volume: 25 Page(s): 358 - 373
    02/07/2017 Authors: Xia S; Lin R; Jin L; Zhao L; Kang H-B; Pan Y; Liu S; Qian G; Qian Z; Konstantakou E
  • The endocannabinoid system: An untapped source for dermatologic therapies
    Volume: 25 Page(s): 41 - 41
    11/01/2016 Authors: Bonchak J; Pollack B; Chisolm S
  • Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.
    J Am Acad Dermatol Volume: 75 Page(s): 639 - 642
    09/01/2016 Authors: Siegel JA; Chren M-M; Weinstock MA; Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group
  • Effective local anesthesia for onabotulinumtoxin A injections to treat hyperhidrosis associated with traumatic amputation.
    Dermatol Online J Volume: 22
    06/15/2016 Authors: Shi LL; Sargen MR; Chen SC; Arbiser JL; Pollack BP
  • Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival.
    Asian J Urol Volume: 3 Page(s): 75 - 81
    04/01/2016 Authors: Sekar RR; De La Calle CM; Patil D; Holzman SA; Baum Y; Sheikh U; Huang JH; Osunkoya AO; Pollack BP; Kissick HT
  • EVALUATION OF TUMOR PD-1 EXPRESSION AS A PROGNOSTIC BIOMARKER IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
    Volume: 195 Page(s): E1161 - E1162
    04/01/2016 Authors: Kim K; Sekar R; DiMarco M; Petit D; Osunkoya A; Sica G; Kissick H; Pollack B; Master V
  • PD-1 expression and its impact on survival in localized clear cell renal cell carcinoma
    Volume: 34
    01/10/2016 Authors: Sekar RR; DiMarco MA; Patil D; Osunkoya AO; Pollack BP; Sica G; Master VA
  • Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.
    Front Pharmacol Volume: 7 Page(s): 327
    01/01/2016 Authors: Kersh AE; Sasaki M; Cooper LA; Kissick HT; Pollack BP
  • Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    JAMA Dermatol Volume: 151 Page(s): 952 - 960
    09/01/2015 Authors: Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N
  • Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.
    Mol Cell Volume: 59 Page(s): 345 - 358
    08/06/2015 Authors: Kang H-B; Fan J; Lin R; Elf S; Ji Q; Zhao L; Jin L; Seo JH; Shan C; Arbiser JL
  • Investigating the function of NONO, a novel double strand break repair factor, and exploring its potential role as a biomarker for melanoma
    Volume: 75
    08/01/2015 Authors: Li S; Shu F; Khan MK; Pollack BP; Li Z; McLemore M; Dynan WS
  • Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.
    Sci Rep Volume: 5 Page(s): 12321
    07/31/2015 Authors: Pulit-Penaloza JA; Sapkota B; Stein Esser E; Compans RW; Pollack BP; Skountzou I
  • Topical application of an epidermal growth factor receptor kinase inhibitor enhances the response to influenza vaccination
    Volume: 135 Page(s): S8 - S8
    05/01/2015 Authors: Pollack BP; Skountzou I; Pulit-Penaloza JA; Compans RW; Sapkota B; Esser ES
  • Evaluation of major histocompatibility complex class I expression in clear cell renal cell carcinoma as a prognostic tool
    Volume: 33
    03/01/2015 Authors: de la Calle CM; Holzman SA; Sheikh U; Huang JH; Kissick HT; Osunkoya AO; Pollack BP; Patil D; Ogan K; Master VA
  • Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma.
    Am J Clin Oncol Volume: 38 Page(s): 119 - 125
    02/01/2015 Authors: Okwan-Duodu D; Pollack BP; Lawson D; Khan MK
  • Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.
    J Virol Volume: 89 Page(s): 1205 - 1217
    01/15/2015 Authors: Mohan GS; Ye L; Li W; Monteiro A; Lin X; Sapkota B; Pollack BP; Compans RW; Yang C
  • High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis.
    Urol Int Volume: 95 Page(s): 72 - 78
    01/01/2015 Authors: Holzman SA; de la Calle CM; Kissick HT; Osunkoya AO; Pollack BP; Patil D; Ogan K; Master VA
  • A protective role of murine langerin cells in immune responses to cutaneous vaccination with microneedle patches.
    Sci Rep Volume: 4 Page(s): 6094
    08/18/2014 Authors: Pulit-Penaloza JA; Esser ES; Vassilieva EV; Lee JW; Taherbhai MT; Pollack BP; Prausnitz MR; Compans RW; Skountzou I
  • MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMA: CORRELATION WITH CLINICAL OUTCOME
    Volume: 191 Page(s): E379 - E380
    04/01/2014 Authors: Holzman S; Osunkoya A; Pollack B; Ogan K; Master V
  • Major histocompatibility complex class I (MHC 1) expression in clear cell renal cell carcinoma: Correlation with clinical outcome.
    Volume: 32
    02/01/2014 Authors: Master VA; Holzman S; Pollack B; Osunkoya AO
  • Major Histocompatibility Complex Class I Expression in Clear Cell Renal Cell Carcinoma: Correlation with Clinical Outcome
    Volume: 94 Page(s): 235A - 235A
    02/01/2014 Authors: Holzman SA; Pollack BP; Master VA; Osunkoya AO
  • Major Histocompatibility Complex Class I Expression in Clear Cell Renal Cell Carcinoma: Correlation with Clinical Outcome
    Volume: 27 Page(s): 235A - 235A
    02/01/2014 Authors: Holzman SA; Pollack BP; Master VA; Osunkoya AO
  • Modulation of MHC expression by BRAFV600E in melanoma
    Volume: 133 Page(s): S224 - S224
    05/01/2013 Authors: Pollack BP; Sapkota B; Hill CE
  • Vemurafenib enhances MHC induction in BRAFV600E homozygous melanoma cells.
    Oncoimmunology Volume: 2 Page(s): e22890
    01/01/2013 Authors: Sapkota B; Hill CE; Pollack BP
  • Inhibitors of oncogenic signal transduction pathways augment the induction of MHC class I molecules by IFN-gamma
    Volume: 132 Page(s): S22 - S22
    05/01/2012 Authors: Pollack BP; Sapkota B
  • EGFR inhibitors, MHC expression and immune responses : Can EGFR inhibitors be used as immune response modifiers?
    Oncoimmunology Volume: 1 Page(s): 71 - 74
    01/01/2012 Authors: Pollack BP
  • Flagellin, a TLR5 Agonist, Reduces GvHD in Allogeneic HSCT Recipients While Enhancing Anti-Viral Immunity: A Novel Therapeutic Approach
    Volume: 118 Page(s): 69 - 69
    11/18/2011 Authors: Hossain MS; Jaye DL; Pollack BP; Farr AB; Roback J; Gewirtz AT; Waller EK
  • Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
    J Immunol Volume: 187 Page(s): 5130 - 5140
    11/15/2011 Authors: Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK
  • Melanoma survival in the United States, 1992 to 2005.
    J Am Acad Dermatol Volume: 65 Page(s): S78 - S86
    11/01/2011 Authors: Pollack LA; Li J; Berkowitz Z; Weir HK; Wu X-C; Ajani UA; Ekwueme DU; Li C; Pollack BP
  • Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes.
    Clin Cancer Res Volume: 17 Page(s): 4400 - 4413
    07/01/2011 Authors: Pollack BP; Sapkota B; Cartee TV
  • Epidermal growth factor receptor inhibitors augment the expression of MHC class I and class II genes
    Volume: 131 Page(s): S95 - S95
    04/01/2011 Authors: Pollack BP; Sapkota B; Cartee TV
  • Voriconazole treatment plus UVB irradiation causes malignant transformation of human HaCaT keratinocyes
    Volume: 131 Page(s): S16 - S16
    04/01/2011 Authors: Berrios RL; Martin-Garrido A; Bonner MY; Pollack BP; Arbiser JL
  • Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise.
    Am J Physiol Regul Integr Comp Physiol Volume: 300 Page(s): R605 - R615
    03/01/2011 Authors: Brown MB; Haack KKV; Pollack BP; Millard-Stafford M; McCarty NA
  • INDUCTION OF ATF3 BY INTERFERON-GAMMA IS MEDIATED BY EGFR ACTIVATION
    JOURNAL OF CUTANEOUS PATHOLOGY Volume: 38 Page(s): 172 - 172
    01/01/2011 Authors: Stoff B; Pollack B; Sapkota B
  • Activating transcription factor 3 (ATF3) expression is increased in erythema multiforme and is regulated by IFN-gamma in human keratinocytes.
    Exp Dermatol Volume: 19 Page(s): e310 - e313
    08/01/2010 Authors: Pollack BP; Sapkota B; Haun PL
  • Expression of activating transcription factor 3 (ATF3) in human melanoma
    Volume: 130 Page(s): S145 - S145
    04/01/2010 Authors: Pollack BP; Sapkota B
  • Epidermal growth factor receptor inhibitors do not suppress the expression of the antimicrobial peptide human beta-defensin 3 in the skin of treated patients
    Volume: 130 Page(s): S55 - S55
    04/01/2010 Authors: Cartee TV; White K; Pollack B; Newton-West M; Swerlick RA
  • Activating transcription factor 3 is expressed in inflamed human skin and is upregulated by interferon-gamma
    Volume: 129 Page(s): S12 - S12
    04/01/2009 Authors: Sapkota B; Pollack BP
  • Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation.
    Photochem Photobiol Volume: 85 Page(s): 652 - 662
    01/01/2009 Authors: Pollack BP; Sapkota B; Boss JM
  • Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Am J Kidney Dis Volume: 51 Page(s): 966 - 975
    06/01/2008 Authors: Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G
  • Sustained trimethylation of histone H3 lysine 4 in the MKP-1 promoter region occurs after a single exposure to UVB
    Volume: 128 Page(s): S210 - S210
    04/01/2008 Authors: Pollack BP; Sapkota B; Boss JM
  • ATF3 is expressed in inflammatory skin diseases and its regulation involves histone acetylation
    JOURNAL OF CUTANEOUS PATHOLOGY Volume: 35 Page(s): 137 - 137
    01/01/2008 Authors: Pollack B; Sapkota B; Haun P; Boss J
  • Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
    Blood Volume: 109 Page(s): 4548 - 4556
    05/15/2007 Authors: Hossain MS; Roback JD; Pollack BP; Jaye DL; Langston A; Waller EK
  • Identification of a novel distal hyperacetylated region within the ATF3 gene
    Volume: 127 Page(s): S93 - S93
    04/01/2007 Authors: Pollack BP; Sapkota B; Boss JM
  • Chronic GVHD decreases anti-cmv immune responses in allogeneic BMT: Defect in T-cell homing
    Volume: 13 Page(s): 126 - 126
    02/01/2007 Authors: Hossain MS; Roback JD; Pollack BP; Jaye DL; Waller EK
  • Pustule-studded plaques after abrasion injury.
    Arch Dermatol Volume: 142 Page(s): 1643 - 1648
    12/01/2006 Authors: Magee KH; Pollack BP; Raugi GJ
  • Presence of p16 hypermethylation and Epstein-Barr virus infection in transplant-associated hematolymphoid neoplasm of the skin.
    J Am Acad Dermatol Volume: 55 Page(s): 794 - 798
    11/01/2006 Authors: Arbiser JL; Mann KP; Losken EM; Cohen C; Reddy K; Kokko K; Pollack B; Fan C-Y; O'Reilly F
  • Changes in chromatin structure induced by Ultraviolet Radiation
    Volume: 126 Page(s): 143 - 143
    04/01/2006 Authors: Pollack BP; Boss JM
  • hTid-1, a human DnaJ protein, modulates the interferon signaling pathway.
    J Biol Chem Volume: 276 Page(s): 49034 - 49042
    12/28/2001 Authors: Sarkar S; Pollack BP; Lin KT; Kotenko SV; Cook JR; Lewis A; Pestka S
  • Hsl7p, the yeast homologue of human JBP1, is a protein methyltransferase.
    Biochem Biophys Res Commun Volume: 274 Page(s): 105 - 111
    07/21/2000 Authors: Lee JH; Cook JR; Pollack BP; Kinzy TG; Norris D; Pestka S
  • The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity.
    J Biol Chem Volume: 274 Page(s): 31531 - 31542
    10/29/1999 Authors: Pollack BP; Kotenko SV; He W; Izotova LS; Barnoski BL; Pestka S
  • Interferon gamma receptor
    EUROPEAN CYTOKINE NETWORK Volume: 9 Page(s): 312 - 312
    09/01/1998 Authors: Pestka S; Kotenko SV; Izotova LS; Pollack BP; Krause CD; He W; Ge Y; Cook JR
  • Identification and functional characterization of a second chain of the interleukin-10 receptor complex.
    EMBO J Volume: 16 Page(s): 5894 - 5903
    10/01/1997 Authors: Kotenko SV; Krause CD; Izotova LS; Pollack BP; Wu W; Pestka S
  • Other kinases can substitute for Jak2 in signal transduction by interferon-gamma.
    J Biol Chem Volume: 271 Page(s): 17174 - 17182
    07/19/1996 Authors: Kotenko SV; Izotova LS; Pollack BP; Muthukumaran G; Paukku K; Silvennoinen O; Ihle JN; Pestka S
  • Interaction between the components of the interferon gamma receptor complex.
    J Biol Chem Volume: 270 Page(s): 20915 - 20921
    09/08/1995 Authors: Kotenko SV; Izotova LS; Pollack BP; Mariano TM; Donnelly RJ; Muthukumaran G; Cook JR; Garotta G; Silvennoinen O; Ihle JN
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements